Skip to main content
logo
Bio-Gene Technology Limited (ASX:BGT)
Australia flag Australia · Delayed Price · Currency is AUD
0.0180
+0.0010 (5.88%)
Sep 18, 2026, 2:29 PM AEST

Bio-Gene Technology Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
---0.020.150.45
Revenue Growth
----87.72%-66.52%611.91%
Gross Profit
-0.34-0.34-0.25-0.3-0.120.22
Operating Income
-2.36-2.36-2.62-2.5-3.18-2.97
Net Income
-2.33-2.33-2.58-2.41-3.1-2.91
Earnings Per Share
-0.01-0.01-0.01-0.01-0.02-0.02
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
1.941.941.142.212.996.34
Total Debt
------
Net Cash (Debt)
1.941.941.142.212.996.34
Net Cash Growth
79.43%70.39%-48.48%-26.11%-52.84%61.24%
Net Cash Per Share
0.010.010.010.010.020.04

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-1.94-1.94-2.54-2.75-3.28-1.99
Capital Expenditures
----0.01--0.01
Free Cash Flow
-1.94-1.94-2.54-2.76-3.28-2
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
-----79.57%49.83%
Operating Margin
----13625.67%-2132.08%-665.67%
Pretax Margin
----13150.54%-2074.48%-653.81%
Profit Margin
----13150.54%-2074.48%-653.81%
FCF Margin
----15065.19%-2195.48%-448.66%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
---538.5892.9951.93